Maternal asthma medication use and the risk of selected birth defects.
about
Self-reported maternal cigarette smoke exposure during the periconceptional period and the risk for omphalocoele.Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).Asthma medication prescribing before, during and after pregnancy: a study in seven European regions.Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better.Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study.Safety of therapeutic options for treating asthma in pregnancy.Genetic and nongenetic etiology of nonsyndromic anorectal malformations: a systematic review.Anorectal malformation: the etiological factors.Pharmacotherapy options to treat asthma during pregnancy.Pharmacological difficulties in the treatment of asthma in pregnant women.Parental risk factors of anorectal malformations: Analysis with a regional population-based control group.Maternal asthma medication use during pregnancy and risk of congenital heart defects.Genome-wide mapping of copy number variations in patients with both anorectal malformations and central nervous system abnormalities.Is maternal use of medicines during pregnancy associated with deciduous molar hypomineralisation in the offspring? A prospective, population-based study.Maternal inhaled fluticasone propionate intake during pregnancy is detected in neonatal cord blood.Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis.
P2860
Q35592239-C9828FAE-3FFA-4C7B-95D3-79933D403F70Q35957504-7EE75FD0-A681-42B6-9B6B-BA6CA997CFCFQ36526636-691D55D9-F897-44FA-840A-AF2F4E9CDB09Q37324761-99FC3562-BE01-4D74-9B7E-017A44D13AD2Q37375534-DB3DD31F-D9DD-495B-97FC-91B59AA1A6A1Q38266412-62CD90CA-B7BF-4904-946E-D0306C1064CBQ38302647-9174BE03-47BF-4049-8B54-7C1D79EC938EQ38434061-016EC42B-6780-43E5-A019-CEAA7CB63B22Q38550944-89FC18C9-8EE2-49E7-8FCB-DAA53B54147EQ39031777-7B9B2612-1C7B-473E-9805-F54471F34A16Q40185449-4B98C192-BBDC-484A-A29B-4E8FC278448FQ41312430-84911DAF-0631-458B-ADC5-66294C6E83F9Q41929373-53115275-10D9-4525-AF6B-B780EACF5DACQ43703283-70DB5A90-D419-4D79-A8F3-CA0DFB53C942Q53721557-A6033539-5943-4FAE-A708-A8F1AA0D9EEFQ55313592-2F3C93AF-4E49-4C7C-83ED-C981AD58EB07
P2860
Maternal asthma medication use and the risk of selected birth defects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Maternal asthma medication use and the risk of selected birth defects.
@en
Maternal asthma medication use and the risk of selected birth defects.
@nl
type
label
Maternal asthma medication use and the risk of selected birth defects.
@en
Maternal asthma medication use and the risk of selected birth defects.
@nl
prefLabel
Maternal asthma medication use and the risk of selected birth defects.
@en
Maternal asthma medication use and the risk of selected birth defects.
@nl
P2093
P2860
P50
P356
P1433
P1476
Maternal asthma medication use and the risk of selected birth defects.
@en
P2093
Charlotte M Druschel
Erin M Bell
Jean Pierre W Munsie
Kimberly Campbell
Marilyn L Browne
Michele L Herdt-Losavio
Richard S Olney
P2860
P304
P356
10.1542/PEDS.2010-2660
P407
P577
2012-01-16T00:00:00Z